GENECENTRIC Trademark

Trademark Overview

On Wednesday, November 27, 2019, a trademark application was filed for GENECENTRIC with the United States Patent and Trademark Office. The USPTO has given the GENECENTRIC trademark a serial number of 88709106. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 29, 2023. This trademark is owned by GENECENTRIC THERAPEUTICS, INC.. The GENECENTRIC trademark is filed in the Pharmaceutical Products category with the following description:

Assays for the medical diagnostic, prognostic and predictive testing of tumors; Medical diagnostic kits containing assays for the medical diagnostic, prognostic and predictive testing of tumors; Biological preparations for the treatment of cancer; Diagnostic preparations for medical purposes; Diagnostic kits comprised of diagnostic reagents and diagnostic assays for testing tissue samples for use in cancer detection, analysis and prognosis; Medical diagnostic reagents; Clinical diagnostic reagents for medical use; Diagnostic kits consisting primarily of enzymes, nucleic acids, buffers, reagents and assays for use in disease testing for medical purposes; Medical diagnostic assays for testing body fluids for medical and prognostic purposes; Medical diagnostic reagents and assays for testing tissue samples; Enzyme preparations for medical purposes; Biological preparations for the detection, diagnosis and monitoring of cancer
genecentric

General Information

Serial Number88709106
Word MarkGENECENTRIC
Filing DateWednesday, November 27, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 29, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 3, 2020

Trademark Statements

Goods and ServicesAssays for the medical diagnostic, prognostic and predictive testing of tumors; Medical diagnostic kits containing assays for the medical diagnostic, prognostic and predictive testing of tumors; Biological preparations for the treatment of cancer; Diagnostic preparations for medical purposes; Diagnostic kits comprised of diagnostic reagents and diagnostic assays for testing tissue samples for use in cancer detection, analysis and prognosis; Medical diagnostic reagents; Clinical diagnostic reagents for medical use; Diagnostic kits consisting primarily of enzymes, nucleic acids, buffers, reagents and assays for use in disease testing for medical purposes; Medical diagnostic assays for testing body fluids for medical and prognostic purposes; Medical diagnostic reagents and assays for testing tissue samples; Enzyme preparations for medical purposes; Biological preparations for the detection, diagnosis and monitoring of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, December 5, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGENECENTRIC THERAPEUTICS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressResearch Triangle Park, NC 27709
Party NameGENECENTRIC THERAPEUTICS, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressResearch Triangle Park, NC 27709

Trademark Events

Event DateEvent Description
Tuesday, May 30, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, May 29, 2023ABANDONMENT - NO USE STATEMENT FILED
Friday, October 7, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 6, 2022SOU EXTENSION 5 GRANTED
Thursday, September 22, 2022SOU EXTENSION 5 FILED
Thursday, September 22, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, April 20, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 18, 2022SOU EXTENSION 4 GRANTED
Monday, April 18, 2022SOU EXTENSION 4 FILED
Monday, April 18, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, September 22, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 20, 2021SOU EXTENSION 3 GRANTED
Monday, September 20, 2021SOU EXTENSION 3 FILED
Monday, September 20, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, April 28, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 26, 2021SOU EXTENSION 2 GRANTED
Monday, April 26, 2021SOU EXTENSION 2 FILED
Monday, April 26, 2021SOU TEAS EXTENSION RECEIVED
Saturday, January 23, 2021CORRECTED NOA E-MAILED
Friday, January 22, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 21, 2021SOU EXTENSION 1 GRANTED
Wednesday, October 28, 2020SOU EXTENSION 1 FILED
Thursday, January 21, 2021DIVISIONAL PROCESSING COMPLETE
Wednesday, October 28, 2020DIVISIONAL REQUEST RECEIVED
Thursday, January 14, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, November 23, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, October 28, 2020TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, October 28, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, April 28, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 3, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 3, 2020PUBLISHED FOR OPPOSITION
Wednesday, February 12, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, January 27, 2020ASSIGNED TO LIE
Tuesday, January 21, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, January 18, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 17, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 17, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 23, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 23, 2019NON-FINAL ACTION E-MAILED
Monday, December 23, 2019NON-FINAL ACTION WRITTEN
Tuesday, December 17, 2019ASSIGNED TO EXAMINER
Thursday, December 5, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, November 30, 2019NEW APPLICATION ENTERED

Related Keywords

genecentric diagnostic medical assays testing reagents preparations purposes prognostic kits cancer